Management of Isolated ST Elevation in V2 with Elevated Troponin I

Initial Assessment and Classification

Patients with isolated ST elevation in V2 and elevated troponin I require an early invasive strategy (<24 hours) as they meet high-risk criteria for acute coronary syndrome requiring urgent coronary angiography and possible intervention, according to the European Society of Cardiology 1
Isolated ST elevation in V2 with elevated troponin I represents myocardial injury that should be considered an acute coronary syndrome (ACS) until proven otherwise, as stated by the European Society of Cardiology 2, 3
The combination of ECG changes and elevated cardiac troponin I indicates myocardial infarction according to consensus definitions from the European Society of Cardiology 3

Obtain serial ECGs to monitor for dynamic changes, which increase risk assessment, as recommended by the European Society of Cardiology 2
Consider additional ECG leads (V7-V9) if standard leads are inconclusive, as left circumflex artery occlusion may be detected only in these leads, according to the European Society of Cardiology 2
Perform serial troponin measurements (at 0h and 3-6h) to establish a rising or falling pattern, which helps distinguish acute from chronic injury, as suggested by the European Society of Cardiology and the American College of Cardiology 1, 4
A rise or fall of cardiac troponin with at least one value above the 99th percentile confirms myocardial infarction in the appropriate clinical context, according to the American College of Cardiology 4
Echocardiography is recommended to evaluate regional wall motion abnormalities and rule out alternative diagnoses, as stated by the European Society of Cardiology 1

This patient meets high-risk criteria based on: rise of cardiac troponin compatible with MI and ST-segment changes (isolated ST elevation in V2), according to the European Society of Cardiology 1
High-risk patients benefit from an early invasive strategy and intensive management, as recommended by the European Society of Cardiology and the American College of Cardiology 1, 4

Administer dual antiplatelet therapy: aspirin 150-300mg loading dose, then 75-150mg daily, and P2Y12 inhibitor (preferably ticagrelor 180mg loading, 90mg twice daily), as recommended by the European Society of Cardiology 1
Start anticoagulation with low molecular weight heparin or unfractionated heparin, according to the European Society of Cardiology 5
Administer beta-blockers and nitrates for ongoing chest pain, as suggested by the European Society of Cardiology 5
Early invasive strategy (<24h) is indicated based on the presence of elevated troponin and ST changes, according to the European Society of Cardiology 1
Continue dual antiplatelet therapy for 12 months unless contraindicated, as recommended by the European Society of Cardiology 1
Initiate high-intensity statin therapy as early as possible, according to the European Society of Cardiology 1

Continuous multilead ST-segment monitoring is recommended to detect recurrent ischemia, as suggested by the European Society of Cardiology 3
Observe for signs of hemodynamic instability (hypotension, pulmonary rales), according to the European Society of Cardiology 5
Repeat troponin measurements to detect possible reinfarction (increase >20% of previous levels), as recommended by the American College of Cardiology 4
Monitor for mechanical complications of MI, according to the European Society of Cardiology 1